Led · Seed · Jul 2026

Immitra Bio is developing scalable, one-time curative in-vivo gene editing therapies built around a mutation-agnostic editing approach and a digital target discovery platform. Its lead candidate, IB-003, is being developed as a potential one-time curative in-vivo gene editing treatment for an inherited anemia. The company's approach is designed to avoid complex ex-vivo cell manipulation, patient conditioning, and stem cell transplantation, aiming to enable off-the-shelf formulations that treat all patients within a given disease regardless of underlying mutation. Immitra Bio says its platform could generate dozens of differentiated therapeutic assets more quickly than highly personalized approaches. The recent CHF 2.4 million pre-seed financing will primarily fund preclinical proof-of-concept work for IB-003 and support additional discovery and validation across the pipeline and platform refinement. The company highlights scalability and commercial viability as core objectives for its technology.

Participated · Seed · Jul 2026

RTDT Laboratories designs ultra-thin, lightweight wireless sensor patches that integrate microelectronic sensors and proprietary algorithms to capture real-time aerodynamic and structural data from wind turbine blades. The patches measure parameters such as aerodynamic pressure, acceleration, vibration, mechanical load and temperature, synchronize timestamps, and transmit data wirelessly to a gateway and then to the cloud to build a digital twin of the blade. Their software suite performs calibration, local and global analyses (including blade kinematics and pressure coefficients), visual analyses and decision recommendations for control, design optimization and maintenance. The patches attach with removable tape without drilling, are offered in two sizes (400×160×4 mm and 160×160×4 mm), and include photovoltaic cells and intelligent battery management for ultra-low-power operation. RTDT was founded in 2022 as an ETH Zurich spin-off by Imad Abdallah, Aris Mukherjee and Konstantinos Tatsis and is pursuing pilot implementations and commercial deployments in the wind-energy sector with a target for large-scale rollout by early 2027.

Participated · Equity · Mar 2026

Eternal.ag designs and builds autonomous robots for greenhouse harvesting, with its first commercial product—Harvester—targeting tomato greenhouses. Harvester is a modular, AI-powered robot that can operate up to 22 hours a day and feeds data back into the system to improve performance. The company uses a simulation-first development approach to train and validate robots in virtual greenhouses, shortening iteration cycles. Eternal.ag envisions fully automated greenhouse operations by 2040 and plans to expand its platform with additional robotic functions for broader greenhouse tasks. Founded by Renji John and Sherry Kunjachan, the company has 26 employees and is headquartered in Cologne with an office in Bengaluru. Following the announced €8 million funding round, Eternal.ag intends to accelerate product development and expand commercial deployments across Europe while extending into additional crop types.

Led · Seed · Nov 2025

Founded in 2023 by Florian Horbach and Mohammad Moghaddas, Zeeg provides a unified platform that merges appointment scheduling with customer-relationship-management capabilities. Each booked meeting instantly generates a comprehensive CRM entry, capturing contact details, company information and interaction history. The solution is developed and hosted entirely on German servers to prevent data transfers to third countries, aligning with strict data-sovereignty requirements. Zeeg’s AI layer streamlines sales processes by surfacing insights from the integrated data. Early traction includes enterprise customers such as Enpal, which uses Zeeg to manage hundreds of daily heat-pump installation appointments. The company has raised €1.1 million in pre-seed capital to accelerate product development and scale its AI capabilities.

Participated · Seed · Oct 2025

Founded in 2024 by David Scott Turner, Carl Strempel, and Bruno Soares, Qala delivers a platform that embeds data observability, lineage, classification, and policy enforcement directly in source code, APIs, and pipelines. The product’s “shift-left” approach allows engineering and compliance teams to map live data flows, trace lineage, automatically classify sensitive fields, and continuously audit against regulations such as GDPR, DORA, and the EU AI Act. By integrating compliance into the development lifecycle, Qala aims to eliminate manual, after-the-fact assessments and give teams immediate clarity and control over data. The founders previously built Imburse Payments, which was acquired by a U.S. insurance-software provider, giving them relevant experience in regulated infrastructure. With AI adoption accelerating, Qala positions its solution as critical for enterprises that need continuous data governance across cloud architectures and microservices. The company plans to use its new capital to accelerate product development of its source-level observability and compliance platform. To date, Qala has secured €1.7 million in pre-seed financing; no revenue or user metrics have been disclosed.